Elles Douven1, Sebastian Köhler1, Syenna H J Schievink1, Robert J van Oostenbrugge2, Julie Staals2, Frans R J Verhey1, Pauline Aalten1. 1. Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience (MHeNs), Alzheimer Center Limburg, Maastricht, the Netherlands. 2. Department of Neurology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands.
Abstract
BACKGROUND: Poststroke fatigue (PSF) is a form of pathological fatigue that can develop after stroke and has a negative impact on functional outcome. PSF is associated with poststroke depression (PSD), which in turn shows similarities with poststroke apathy (PSA). This study aimed at disentangling the temporal associations between PSF and PSD and between PSF and PSA. METHODS: A total of 250 stroke patients were included, of which 243 completed the Fatigue Severity Scale, Montgomery-Åsberg Depression Rating Scale, and Apathy Evaluation Scale at 3 months poststroke, with follow-up measurements at 6 and 12 months after initial testing. Linear mixed models and linear regressions were performed to evaluate the temporal associations between PSF and PSD, and between PSF and PSA. RESULTS: PSF was present in 119 patients (49%), of whom 62 patients also had PSD (26%), and 21 patients (9%) also had PSA. At baseline, PSF patients showed higher depression levels, which remained stable at follow-up. PSD patients had higher fatigue levels compared with no-PSD patients at baseline, which remained stable at follow-up. No association between apathy and fatigue was found at baseline and no interaction with time was found. Change in fatigue from baseline to 12-month follow-up was associated with change in depression and with change in apathy. CONCLUSIONS: Bidirectional associations were found between PSF and PSD. In treatment and rehabilitation programs, early focus on the presence of PSD and PSF is important, since these conditions tend to persist. As there are currently more treatment options for PSD, attention for PSD is important and might also have a beneficial effect on PSF.
BACKGROUND:Poststroke fatigue (PSF) is a form of pathological fatigue that can develop after stroke and has a negative impact on functional outcome. PSF is associated with poststroke depression (PSD), which in turn shows similarities with poststroke apathy (PSA). This study aimed at disentangling the temporal associations between PSF and PSD and between PSF and PSA. METHODS: A total of 250 strokepatients were included, of which 243 completed the Fatigue Severity Scale, Montgomery-Åsberg Depression Rating Scale, and Apathy Evaluation Scale at 3 months poststroke, with follow-up measurements at 6 and 12 months after initial testing. Linear mixed models and linear regressions were performed to evaluate the temporal associations between PSF and PSD, and between PSF and PSA. RESULTS: PSF was present in 119 patients (49%), of whom 62 patients also had PSD (26%), and 21 patients (9%) also had PSA. At baseline, PSF patients showed higher depression levels, which remained stable at follow-up. PSDpatients had higher fatigue levels compared with no-PSDpatients at baseline, which remained stable at follow-up. No association between apathy and fatigue was found at baseline and no interaction with time was found. Change in fatigue from baseline to 12-month follow-up was associated with change in depression and with change in apathy. CONCLUSIONS: Bidirectional associations were found between PSF and PSD. In treatment and rehabilitation programs, early focus on the presence of PSD and PSF is important, since these conditions tend to persist. As there are currently more treatment options for PSD, attention for PSD is important and might also have a beneficial effect on PSF.
Authors: Justine A Aaronson; Coen A M van Bennekom; Winni F Hofman; Tijs van Bezeij; Joost G van den Aardweg; Erny Groet; Wytske A Kylstra; Ben Schmand Journal: Sleep Date: 2015-09-01 Impact factor: 5.849
Authors: Anners Lerdal; Linda N Bakken; Eli F Rasmussen; Christer Beiermann; Signy Ryen; Solveig Pynten; Ashild S Drefvelin; Anne M Dahl; Gunhild Rognstad; Arnstein Finset; Kathryn A Lee; Hesook Suzie Kim Journal: Disabil Rehabil Date: 2010-06-03 Impact factor: 3.033
Authors: M Kaminska; R J Kimoff; A Benedetti; A Robinson; A Bar-Or; Y Lapierre; K Schwartzman; D A Trojan Journal: Mult Scler Date: 2011-12-19 Impact factor: 6.312
Authors: Amytis Towfighi; Bruce Ovbiagele; Nada El Husseini; Maree L Hackett; Ricardo E Jorge; Brett M Kissela; Pamela H Mitchell; Lesli E Skolarus; Mary A Whooley; Linda S Williams Journal: Stroke Date: 2016-12-08 Impact factor: 7.914
Authors: Harsimarpreet Kaur; Ashima Nehra; Sakshi Chopra; Hemchandra Sati; Rohit Bhatia; Senthil S Kumaran; R M Pandey; M V Padma Srivastava Journal: Ann Indian Acad Neurol Date: 2020-09-25 Impact factor: 1.383
Authors: Mindaugas Jurgelis; Wei Binh Chong; Kelly J Atkins; Patrick S Cooper; James P Coxon; Trevor T-J Chong Journal: Sci Rep Date: 2021-11-15 Impact factor: 4.379
Authors: Kristine M Ulrichsen; Knut K Kolskår; Geneviève Richard; Mads Lund Pedersen; Dag Alnaes; Erlend S Dørum; Anne-Marthe Sanders; Sveinung Tornås; Luigi A Maglanoc; Andreas Engvig; Hege Ihle-Hansen; Jan E Nordvik; Lars T Westlye Journal: Brain Behav Date: 2022-06-06 Impact factor: 3.405